{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-096245","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.197735+00:00","generated_at":"2026-05-30T02:16:30.074695+00:00","sec_items":["1.01","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"CERo Therapeutics enters $20.6M stock purchase agreement and shareholders approve reverse split and equity plan","bullets":["Entered into a purchase agreement with Keystone Capital Partners, LLC to sell up to $20,589,384.23 of common stock.","Shareholders approved a reverse stock split at a ratio between 1:25 and 1:150, set by the board.","Shareholders approved issuance of shares upon conversion of Series C Preferred and exercise of warrants from September 2024.","Shareholders approved an increase of 20,845,391 shares under the 2024 Equity Incentive Plan.","Company had previously sold 23,377,921 shares for $4.41 million under the prior purchase agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-096245","json":"https://secwatch.observer/filing/0001213900-24-096245.json","markdown":"https://secwatch.observer/filing/0001213900-24-096245.md","text":"https://secwatch.observer/filing/0001213900-24-096245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024096245/0001213900-24-096245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390024096245/ea0220614-8k_cerothera.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:16:30.074695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}